Tanac Oral Pain Reliever Liquid
NDC Package 69626-0049-4

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Tanac Oral Pain Reliever (benzocaine) liquids is apply product with cotton swab or clean fingertip to the affected areaadults and children 2 years of age and older: use up times 4 times daily or as directed by a dentist or doctor. This formulation utilizes a liquid delivery system. Marketed by Leosons Overseas Corp, this product is identified by NDC 69626-0049 and is authorized under FDA application M022.

Identification & Billing

NDC Package Code
69626-0049-4
Package Description
1 BOTTLE in 1 CARTON / 13.3 mL in 1 BOTTLE
Product Code
69626-0049
11-Digit Billing Format
69626004904
RxNorm Crosswalk
  • RxCUI: 1053339 - Tanac Liquid 10 % Mucous Membrane Topical Solution
  • RxCUI: 1053339 - benzocaine 100 MG/ML Mucous Membrane Topical Solution [Tanac Liquid]
  • RxCUI: 1053339 - Tanac Liquid 100 MG/ML Mucous Membrane Topical Solution
  • RxCUI: 583152 - benzocaine 10 % Mucous Membrane Topical Solution
  • RxCUI: 583152 - benzocaine 100 MG/ML Mucous Membrane Topical Solution

Clinical Specifications

Proprietary Name
Tanac Oral Pain Reliever
Non-Proprietary Name
Benzocaine
Substance Name
Benzocaine
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
BENZOCAINE 10 g/100mL
Pharmacologic Class
Usage Information
Apply product with cotton swab or clean fingertip to the affected areaadults and children 2 years of age and older: use up times 4 times daily or as directed by a dentist or doctor. Children should be supervised in the use of this product.children under 2 years of age: do not use

Regulatory & Marketing

Labeler Name
Leosons Overseas Corp
Product Type
Human Otc Drug
FDA Application #
M022
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
01-01-2015
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69626-0049-4 identifies a specific commercial package of 1 bottle in 1 carton / 13.3 ml in 1 bottle of Tanac Oral Pain Reliever, a human over the counter drug labeled by Leosons Overseas Corp. This liquid is formulated for oral use and contains benzocaine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Leosons Overseas Corp on January 01, 2015. The current certification is valid through December 31, 2026.

How is this Leosons Overseas Corp product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69626004904. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
69626-0049-4
11-Digit CMS (5-4-2)
69626-0049-04

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.